Details for Patent: 9,119,876

Which drugs does patent 9,119,876 protect, and when does it expire?

Patent 9,119,876 protects ADRENALIN and is included in two NDAs.

This patent has seven patent family members in seven countries.

Summary for Patent: 9,119,876

Patent landscape, scope, and claims:

Title:	Epinephrine formulations
Abstract:	Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
Inventor(s):	Kannan; Vinayagam (Rochester, MI), Irish; Patrick (Sterling Heights, MI), Bergren; Michael (Henderson, NV)
Assignee:	PAR PHARMACEUTICAL, INC. (Woodcliff Lake, NJ)
Application Number:	14/657,990
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,119,876
Patent Claim Types: see list of patent claims	Composition;

Drugs Protected by US Patent 9,119,876

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Endo Operations	ADRENALIN	epinephrine	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	204200-001	Dec 7, 2012		RX	Yes	Yes	9,119,876		Y
Endo Operations	ADRENALIN	epinephrine	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	204640-001	Dec 18, 2013	AP	RX	Yes	Yes	9,119,876		Y

International Family Members for US Patent 9,119,876

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2016233682
Canada	2978464
China	107614017